Actively Recruiting
Development of Novel Physiological CMR Methods in Health and Disease
Led by Sheffield Teaching Hospitals NHS Foundation Trust · Updated on 2026-03-18
135
Participants Needed
1
Research Sites
648 weeks
Total Duration
On this page
AI-Summary
What this Trial Is About
Physiological cardiovascular stress test plays a crucial role in the assessment of patients with suspected heart disease. There are several methods of cardiac physiological stress tests and each of them offer varied insight into cardiac physiological adaptation: passive leg raise, intra-venous fluid challenge, pharmacological stressors and physical exercise stress test. Echocardiography, which is the mainstay for the non-invasive rest/stress assessment of the left ventricular (LV) haemodynamics has several limitations. Novel methods of CMR imaging allow to map intra-cardiac flow in three-dimension using novel flow acquisitions. These novel flow acquisitions are called four-dimensional flow CMR, where the fourth dimension is time. Additionally, traditional cine CMR imaging for functional assessment can now be done without breath-holds using advanced acceleration methods, allowing them to be used during exercise. A comprehensive understanding of functional-flow coupling at rest, during increased pre-load (fluid challenge) to the heart or during exercise, is lacking in the literature. There is an important need to validate these novel CMR methods for developing mechanistic insight into physiological cardiac adaptation to increased pre-load or to exercise in health and how it alters in heart disease.
CONDITIONS
Official Title
Development of Novel Physiological CMR Methods in Health and Disease
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Healthy volunteers aged 20 to 80, recruited from Sheffield Teaching Hospitals staff
- Patients aged 20 to 80 with suspected or known heart disease in specified clinical groups
- Ability to provide written informed consent
You will not qualify if you...
- Inability to complete the study protocol due to severe heart failure requiring intravenous therapy
- History of myocardial infarction, acute coronary syndrome, or cardiomyopathy in suspected CAD and acute myocardial infarction groups
- Significant valvular heart disease
- Presence of atrial fibrillation
- Contraindications to MRI as per standard screening
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 1 location
1
Sheffield Teaching Hospitals NHS FT
Sheffield, England, United Kingdom, S10 2JF
Actively Recruiting
Research Team
H
Helen Denney
CONTACT
A
Amber Ford
CONTACT
How is the study designed?
Study Type
INTERVENTIONAL
Masking
NONE
Allocation
NON_RANDOMIZED
Model
PARALLEL
Primary Purpose
OTHER
Number of Arms
6
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here